8'-Fuoro-2',4'-dihydro-1'H-spiro[piperidine-4,3'-quinoline]-2'-one hydrochloride
95%
- Product Code: 67960
CAS:
1439898-04-0
| Molecular Weight: | 270.73 g./mol | Molecular Formula: | C₁₃H₁₆ClFN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD26096865 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It serves as a key intermediate in the synthesis of potential therapeutic agents targeting neurological conditions such as anxiety, depression, and cognitive impairments. Its unique structure allows it to interact with specific receptors in the brain, making it valuable for drug discovery efforts aimed at modulating neurotransmitter activity. Additionally, it is explored for its potential in developing novel treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. Researchers also investigate its role in enhancing the efficacy and safety profiles of CNS-targeting drugs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | $8,398.57 |
+
-
|
8'-Fuoro-2',4'-dihydro-1'H-spiro[piperidine-4,3'-quinoline]-2'-one hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It serves as a key intermediate in the synthesis of potential therapeutic agents targeting neurological conditions such as anxiety, depression, and cognitive impairments. Its unique structure allows it to interact with specific receptors in the brain, making it valuable for drug discovery efforts aimed at modulating neurotransmitter activity. Additionally, it is explored for its potential in developing novel treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. Researchers also investigate its role in enhancing the efficacy and safety profiles of CNS-targeting drugs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :